RDWM
ABBV icon

Red Door Wealth Management’s AbbVie ABBV Stock Holding History

Red Door Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
48,414
+506
+1% +$109K 1.11% 27
2026
Q1 		$10.4M Buy
47,908
+798
+2% +$177K 1.08% 27
2025
Q4 		$10.8M Buy
47,110
+345
+0.7% +$78.6K 1.12% 26
2025
Q3 		$10.8M Buy
46,765
+1,153
+3% +$235K 1.15% 22
2025
Q2 		$8.47M Buy
45,612
+6,217
+16% +$1.16M 1.01% 28
2025
Q1 		$8.25M Buy
39,395
+3,809
+11% +$740K 1.22% 24
2024
Q4 		$6.32M Buy
35,586
+24,651
+225% +$4.53M 0.97% 35
2024
Q3 		$2.16M Buy
10,935
+785
+8% +$147K 0.36% 61
2024
Q2 		$1.74M Sell
10,150
-134
-1% -$22.2K 0.31% 66
2024
Q1 		$1.87M Buy
10,284
+1,777
+21% +$306K 0.36% 60
2023
Q4 		$1.32M Buy
8,507
+960
+13% +$140K 0.29% 64
2023
Q3 		$1.12M Sell
7,547
-289
-4% -$42.4K 0.28% 66
2023
Q2 		$1.06M Sell
7,836
-304
-4% -$44.6K 0.23% 74
2023
Q1 		$1.3M Sell
8,140
-69
-0.8% -$10.5K 0.41% 59
2022
Q4 		$1.33M Buy
8,209
+749
+10% +$115K 0.44% 61
2022
Q3 		$1M Buy
7,460
+283
+4% +$40.6K 0.38% 64
2022
Q2 		$1.1M Buy
7,177
+403
+6% +$61.6K 0.41% 61
2022
Q1 		$1.1M Buy
6,774
+2,706
+67% +$393K 0.37% 61
2021
Q4 		$550K Buy
4,068
+148
+4% +$17.5K 0.18% 93
2021
Q3 		$423K Sell
3,920
-124
-3% -$14.2K 0.16% 100
2021
Q2 		$455K Buy
4,044
+562
+16% +$63.3K 0.18% 94
2021
Q1 		$378K Buy
3,482
+34
+1% +$3.64K 0.19% 89
2020
Q4 		$369K Buy
3,448
+228
+7% +$21.9K 0.22% 82
2020
Q3 		$282K Sell
3,220
-31
-1% -$2.92K 0.21% 82
2020
Q2 		$319K Buy
3,251
+304
+10% +$26.8K 0.23% 78
2020
Q1 		$224K Sell
2,947
-32
-1% -$2.73K 0.21% 77
2019
Q4 		$262K Buy
+2,979
New +$247K 0.23% 85

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Red Door Wealth Management's ABBV Position: Q2 2026 in Review

Red Door Wealth Management increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $109K and bringing the position to 48,414 shares worth $12.2M. The position accounts for 1.11% of the portfolio, ranked #27.

Red Door Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 1,191 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Red Door Wealth Management held 48,414 shares of AbbVie worth $12.2M as of Q2 2026.
  • Red Door Wealth Management bought 506 AbbVie shares in Q2 2026, an estimated $109K.
  • AbbVie made up 1.11% of Red Door Wealth Management's portfolio in Q2 2026, its #27 holding.
  • Red Door Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 1,191 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.